US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Future Vision II Acquisition Corporation (FVN) 銘柄情報

Future Vision II Acquisition Corporation (FVN)

10.88

0.00

(0.00%)

終了 6月13日 5:00AM

10.91

0.00

(0.00%)

取引時間後: 6:10AM

Future Vision II Acquisition Corporation (FVN) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

10.88

( - )

買値

8.20

売値

21.31

出来高

22

10.92 日の範囲 10.92

10.30 52 週間の範囲 11.06

時価総額

前日終値

10.88

始値

10.92

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 26,698

発行済株式数

7,544,000

配当利回り

PER

17.55

1 株当たり利益 (EPS)

0.62

歳入

-

純利益

2.03M

Future Vision II Acquisition Corp. does not have significant operations. It intends to focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Future Vision II Acquisition Corp. was inc... Future Vision II Acquisition Corp. does not have significant operations. It intends to focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Future Vision II Acquisition Corp. was incorporated in 2024 and is headquartered in Shanghai, China. 詳細を表示

セクター

-

業界

-

本社

Shanghai, China

設立

2026

Future Vision II Acquisition Corporation is listed in the sector of the ナスダック市場 with ticker FVN. The last closing price for Future Vision II Acquisi... was US$10.88. Over the last year, Future Vision II Acquisi... shares have traded in a share price range of US$ 10.30 to US$ 11.06.

Future Vision II Acquisi... currently has 7,544,000 shares in issue. The market capitalisation of Future Vision II Acquisi... is US$82.08 million. Future Vision II Acquisi... has a price to earnings ratio (PE ratio) of 17.55.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.01	0.0919963201472	10.87	10.91	10.85	3568	10.87896849	CS
4	0.04	0.369003690037	10.84	11.06	10.76	3552	10.85244236	CS
12	0.16	1.49253731343	10.72	11.06	10.72	9790	10.83479971	CS
26	0.3	2.83553875236	10.58	11.06	10.54	9041	10.73411637	CS
52	0.53	5.12077294686	10.35	11.06	10.3	6325	10.64303417	CS
156	0.89	8.90890890891	9.99	11.06	9.95	13347	10.22311948	CS
260	0.89	8.90890890891	9.99	11.06	9.95	13347	10.22311948	CS

FVN - Frequently Asked Questions (FAQ)

What is the current Future Vision II Acquisition Corporation share price?

The current share price of Future Vision II Acquisition Corporation is US$ 10.88

How many Future Vision II Acquisition Corporation shares are in issue?

Future Vision II Acquisition Corporation has 7,544,000 shares in issue

What is the market cap of Future Vision II Acquisition Corporation?

The market capitalisation of Future Vision II Acquisition Corporation is USD 82.08M

What is the 1 year trading range for Future Vision II Acquisition Corporation share price?

Future Vision II Acquisition Corporation has traded in the range of US$ 10.30 to US$ 11.06 during the past year

What is the PE ratio of Future Vision II Acquisition Corporation?

The price to earnings ratio of Future Vision II Acquisition Corporation is 17.55

What is the registered address of Future Vision II Acquisition Corporation?

The registered address for Future Vision II Acquisition Corporation is Xiandai Tongxin Building, Shanghai

Split T

Split T 3分前

Musk has literally guaranteed this employees a verybhansome and maximum return with no chance of the stock catering before they all dispose of what they wish to sell. SMART MOVE FOR HIM AND HIS EMPLOYEE'S . iMo they will be able to buy back in when it tanks for the first time. IT is not worth the

81vette

81vette 17分前

I understand now,merger was complete but had a 20 day mandatory conversion waiting period from filing date ,it ended Wednesday and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good with insti

RockQQ

RockQQ 18分前

Wow, we always suspected! Good link!

RockQQ

midastouch017

midastouch017 20分前

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

MartinLutherKing

MartinLutherKing 20分前

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

janice shell

janice shell 30分前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 30分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 35分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 36分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 38分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 42分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 45分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 52分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 53分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 53分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 54分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 54分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 57分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 57分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 1時間前

Just give me $1.50

Just give me $1.50 1時間前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 1時間前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

Future Vision II Acquisi...

KraneShares ICAV

Augur Reputation v2

Sun Summit Minerals

Peninsula Energy

MustGrow Biologics

Fintech Scion (EM)

Exchange Traded

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。